PREDICTIVE ONCOLOGY INC (POAI) Stock Income Statement
NASDAQ:POAI - Nasdaq - US74039M3097 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.35M | 1.62M | 1.63M | 1.51M | 1.42M | |||
| Cost Of Goods | 685.60K | 826.10K | 609.20K | 510.00K | 490.00K | |||
| Gross Profit | 660.80K | 797.70K | 1.02M | 1.00M | 930.00K | |||
| Operating Expenses | 10.57M | 11.74M | 12.97M | 16.26M | 14.40M | |||
| Selling, General, and Administrative Expenses | 7.59M | 8.72M | 9.62M | 12.47M | 11.71M | |||
| Operating Income | -9.91M | -10.94M | -11.95M | -15.26M | -13.47M | |||
| Interest Income/Expense | 400.00 | 1.40K | 12.50K | 120.00K | 160.00K | |||
| Other Income/Expense | 62.60K | 77.90K | 87.70K | 180.00K | -60.00K | |||
| Non Recurring Items | N/A | N/A | -162.90K | -10.77M | -6.96M | |||
| Income Before Taxes | -9.85M | -10.86M | -12.02M | -25.74M | -20.32M | |||
| Income Tax | N/A | N/A | N/A | 0.00 | -660.00K | |||
| Net Income | -10.89M | -12.66M | -13.98M | -25.74M | -19.66M | |||
| EBITDA | -9.88M | -10.78M | -11.71M | -13.95M | -12.13M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.82 | -2.32 | -3.48 | -7.05 | -7.16 | |||
| Non GAAP EPS | N/A | N/A | N/A | N/A | -0.37 | |||
| Statistics | ||||||||
| Gross Profit Margin | 49.08% | 49.13% | 62.57% | 66.23% | 65.49% | |||
| Profit Margin | -808.77% | -779.92% | -859.13% | -1704.64% | -1384.51% | |||
| Operating Profit Margin | -736.38% | -673.70% | -734.46% | -1010.60% | -948.59% | |||
All data in USD